//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Now available: listen to A/Prof Abhijit Pal explain how to improve access to clinical trials for individuals from culturally and linguistically diverse backgrounds. Find it on YouTube: tinyurl.com/th7az96n #CommonSenseOncology #CancerCare
15d
Common Sense Oncology
CSO at #ASCO2026: Panelists Drs. Sam Stevens, Michelle Tregear, Rachel Riechelmann, Christopher Jackson, and Chris Booth discussed their ASCO Educational Book paper: Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter. Read the paper for more: tinyurl.com/uc4tfkyj
We're looking forward to seeing you at our ASCO sessions this weekend! For details, see below. 👇 #ASCO2026
8d
Does chest wall radiation therapy after mastectomy still work in the oncology landscape today? Listen to four experts discuss the SUPREMO trial for the Indian context, now live on YouTube. ▶️ Catch it here: youtu.be/y-gsf8ikwaQ #CommonSenseOncology #CancerCare
Join us on May 27 @ 7 pm AEST for a webinar about improving access to clinical trials for individuals from culturally and linguistically diverse backgrounds, featuring A/Prof Abhijit Pal. Register on Zoom: tinyurl.com/3fec2k6k #CommonSenseOncology #CancerCare
Check out Common Sense Oncology's latest open-access ASCO Educational Book article by Drs. Ian Tannock, Ajay Aggarwal, Haydee Verduzco-Aguirre, and Brooke Wilson: "Value, Access, and High-Quality Medical Oncology Care: Can We Have It All?" tinyurl.com/yk42mju6 #CommonSenseOncology #CancerCare
28d
15d
29d
CSO at ASCO: Panelists Drs. Ian Tannock, Ajay Aggarwal, Haydeé Verduzco, and Brooke Wilson discussed their recent ASCO Educational Book paper: Value, Access, and Quality Care: Can We Have It All? Read the paper for more: ascopubs.org/doi/10.1200/... #CommonSenseOncology #CancerCare
22d
Join CSO at ASCO! Attend CSO’s 2 exciting educational sessions, in-person or online: 🔵 Value, Access, and Quality Care: Can We Have It All?, May 30 🔵 Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter, May 31 ASCO program: tinyurl.com/yth9v2j5 #CommonSenseOncology #ASCO2026
Video
Common Sense Oncology
8d
Common Sense Oncology
1mo
Common Sense Oncology
Common Sense Oncology
Common Sense Oncology
Common Sense Oncology
Join CSO at ASCO! Attend CSO’s 2 exciting educational sessions, in-person or online: 🔵 Value, Access, and Quality Care: Can We Have It All?, May 30 🔵 Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter, May 31 ASCO program: tinyurl.com/yth9v2j5 #CommonSenseOncology #ASCO2026
1mo
Common Sense Oncology
"COMMON SENSE ONCOLOGY" EN IBEROAMÉRICA 🌎Oncólogos de referencia de 🇪🇸🇲🇽🇧🇷🇨🇴y🇨🇱debatirán sobre acceso a tratamientos, equidad y sostenibilidad en cáncer, compartiendo realidad de sus países y propuestas para una #CommonSenseOncology @csoncol.bsky.social Registro gratis: commonsenseoncology.org/events/
Common Sense Oncology
4d
Events Join CSO at an Upcoming Event! 2026 June 16, 20:00 h CEST (Madrid) “COMMON SENSE ONCOLOGY” EN CONTEXTO IBEROAMERICANO: Retos y oportunidades Este webinar reunirá a destacados oncólogos médicos ...
commonsenseoncology.org
Cancer care and movement: landmark clinical trial shows exercise-as-treatment improves colon cancer patient survival and reduces costs to healthcare systems. tinyurl.com/pas9fvtr #CommonSenseOncology #CancerCare
CSO Events - Common Sense Oncology
10d
Supervised exercise programs, which cost about $3,000 per patient over three years, boost survival rates and save the health system money, study shows.
tinyurl.com
This $3,000 program drastically cuts colon cancer recurrence. Doctors say it should be funded like a drug
Rodrigo Lastra
Common Sense Oncology